NCT01313689 2018-11-08Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic LeukemiaNovartisPhase 3 Completed122 enrolled 24 charts
NCT00742144 2017-11-17Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic LeukemiaGlaxoSmithKlinePhase 1 Completed6 enrolled